# ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study

Study · id `cardio:ct-nct04609111` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04609111](<https://clinicaltrials.gov/study/NCT04609111>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04609111

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 6002 participants.

## Technical summary

Registry record NCT04609111. Randomized; no masking; primary purpose treatment. Start 2021-01-29 (actual); primary completion 2023-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 6002 participants (enrolled count; ClinicalTrials.gov record NCT04609111, source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)
- Started: 2021-01-29 (actual) (ClinicalTrials.gov record NCT04609111, source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)
- Primary completion: 2023-12-31 (actual) (ClinicalTrials.gov record NCT04609111, source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT04609111, source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)
- Countries: Japan (ClinicalTrials.gov record NCT04609111, source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04609111-2024-06-14`, retrieved 2026-10-31)

## The registry's words

- Brief title: ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
- Acronym: STOPDAPT-3
- Condition: Acute Coronary Syndrome
- Intervention (Drug): No aspirin
- Intervention (Drug): 1-month DAPT
- Lead sponsor: Kyoto University, Graduate School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Kyoto University, Graduate School of Medicine (`cardio:org-kyoto-university-graduate-school-of-medicine`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial (`cardio:pubmed-37994553`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial (`cardio:pubmed-38972535`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial (`cardio:pubmed-39215959`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial (`cardio:pubmed-39863419`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial (`cardio:pubmed-40365675`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation (`cardio:pubmed-40471776`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation (`cardio:pubmed-40988628`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 30ad20ffb27772f44bb75328a4fc0ed09b4f44073b5c028245f50f205464e599
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
